Identification	O
and	O
purification	O
of	O
a	O
human	B-protein
immunoglobulin-enhancer-binding	I-protein
protein	I-protein
(	O
NF-kappa	B-protein
B	I-protein
)	O
that	O
activates	O
transcription	O
from	O
a	O
human	B-DNA
immunodeficiency	I-DNA
virus	I-DNA
type	I-DNA
1	I-DNA
promoter	I-DNA
in	O
vitro	O
.	O

The	O
enhancer-binding	B-protein
factor	I-protein
NF-kappa	I-protein
B	I-protein
,	O
which	O
is	O
found	O
only	O
in	O
cells	O
that	O
transcribe	O
immunoglobulin	B-DNA
light	I-DNA
chain	I-DNA
genes	I-DNA
,	O
has	O
been	O
purified	O
from	O
nuclear	O
extracts	O
of	O
Namalwa	B-cell_line
cells	I-cell_line
(	O
human	B-cell_line
Burkitt	I-cell_line
lymphoma	I-cell_line
cells	I-cell_line
)	O
by	O
sequence-specific	O
DNA	O
affinity	O
chromatography	O
.	O

The	O
purified	O
NF-kappa	B-protein
B	I-protein
has	O
been	O
identified	O
as	O
a	O
51-kDa	B-protein
polypeptide	I-protein
by	O
UV-crosslinking	O
analysis	O
.	O

``	O
Footprint	O
''	O
and	O
methylation-interference	O
analyses	O
have	O
shown	O
that	O
purified	O
NF-kappa	B-protein
B	I-protein
has	O
a	O
binding	O
activity	O
specific	O
for	O
the	O
kappa	B-DNA
light	I-DNA
chain	I-DNA
enhancer	I-DNA
sequence	I-DNA
.	O

The	O
purified	O
factor	O
activated	O
in	O
vitro	O
transcription	O
of	O
the	O
human	B-DNA
immunodeficiency	I-DNA
virus	I-DNA
type	I-DNA
I	I-DNA
promoter	I-DNA
by	O
binding	O
to	O
an	O
upstream	B-DNA
NF-kappa	I-DNA
B-binding	I-DNA
site	I-DNA

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

85	NULL
,	NULL
pp	NULL
.	NULL

4700-4704	NULL
,	NULL
July	NULL
1988	NULL
Biochemistry	NULL
Identification	NULL
and	NULL
purification	NULL
of	NULL
a	NULL
human	NULL
immunoglobulin-enhancer-binding	NULL
protein	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
that	NULL
activates	NULL
transcription	NULL
from	NULL
a	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
promoter	NULL
in	NULL
vitro	NULL
(	NULL
transcription	NULL
factor	NULL
/lymphoid-specific	NULL
protein	NULL
/UV	NULL
crosslinking	NULL
/DNase	NULL
I	NULL
``	NULL
footprinting	NULL
``	NULL
/methylation	NULL
interference	NULL
)	NULL
KryosH1	NULL
KAWAKAMI	NULL
,	NULL
CLAUS	NULL
SCHEIDEREIT	NULL
,	NULL
AND	NULL
RoseRrt	NULL
G.	NULL
RoEDER	NULL
Laboratory	NULL
of	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
The	NULL
Rockefeller	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
10021	NULL
Communicated	NULL
by	NULL
James	NULL
E.	NULL
Darnell	NULL
,	NULL
Jr.	NULL
,	NULL
March	NULL
21	NULL
,	NULL
1988	NULL
ABSTRACT	NULL
The	NULL
enhancer-binding	NULL
factor	NULL
NF-B	NULL
,	NULL
which	NULL
is	NULL
found	NULL
only	NULL
in	NULL
cells	NULL
that	NULL
transcribe	NULL
immunoglobulin	NULL
light	NULL
chain	NULL
genes	NULL
,	NULL
has	NULL
been	NULL
purified	NULL
from	NULL
nuclear	NULL
extracts	NULL
of	NULL
Namalwa	NULL
cells	NULL
(	NULL
human	NULL
Burkitt	NULL
lymphoma	NULL
cells	NULL
)	NULL
by	NULL
sequence-specific	NULL
DNA	NULL
affinity	NULL
chromatography	NULL
.	NULL

The	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
identified	NULL
as	NULL
a	NULL
51-kDa	NULL
polypeptide	NULL
by	NULL
UV-crosslinking	NULL
analysis	NULL
.	NULL

``	NULL
*Footprint	NULL
``	NULL
and	NULL
methylation-interference	NULL
analyses	NULL
have	NULL
shown	NULL
that	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
a	NULL
binding	NULL
activity	NULL
specific	NULL
for	NULL
the	NULL
x	NULL
light	NULL
chain	NULL
enhancer	NULL
sequence	NULL
.	NULL

The	NULL
purified	NULL
factor	NULL
activated	NULL
in	NULL
vitro	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
I	NULL
promoter	NULL
by	NULL
binding	NULL
to	NULL
an	NULL
upstream	NULL
NF-KB-binding	NULL
site	NULL
.	NULL

The	NULL
immunoglobulin	NULL
heavy	NULL
and	NULL
light	NULL
chain	NULL
genes	NULL
are	NULL
transcribed	NULL
only	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
B	NULL
lineage	NULL
.	NULL

This	NULL
results	NULL
from	NULL
tissue-specific	NULL
gene	NULL
rearrangements	NULL
(	NULL
1	NULL
)	NULL
and	NULL
from	NULL
the	NULL
presence	NULL
of	NULL
tissue-specific	NULL
promoters	NULL
and	NULL
tissue-specific	NULL
enhancers	NULL
(	NULL
reviewed	NULL
in	NULL
refs	NULL
.	NULL

2-4	NULL
)	NULL
.	NULL

As	NULL
found	NULL
for	NULL
many	NULL
other	NULL
promoters	NULL
and	NULL
enhancers	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
,	NULL
those	NULL
present	NULL
in	NULL
immunoglobulin	NULL
genes	NULL
each	NULL
'contain	NULL
multiple	NULL
elements	NULL
that	NULL
bind	NULL
either	NULL
common	NULL
or	NULL
tissue-specific	NULL
factors	NULL
(	NULL
reviewed	NULL
in	NULL
refs	NULL
.	NULL

2-4	NULL
)	NULL
.	NULL

One	NULL
of	NULL
these	NULL
sites	NULL
in	NULL
the	NULL
«	NULL
enhancer	NULL
binds	NULL
a	NULL
factor	NULL
called	NULL
NF-KB	NULL
(	NULL
4	NULL
,	NULL
7	NULL
)	NULL
and	NULL
is	NULL
the	NULL
single	NULL
most	NULL
critical	NULL
element	NULL
for	NULL
lymphoid	NULL
cell	NULL
expression	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
additional	NULL
observation	NULL
that	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
is	NULL
present	NULL
in	NULL
mature	NULL
B	NULL
cells	NULL
and	NULL
plasma	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
pre-B	NULL
or	NULL
T	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
suggested	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
does	NULL
play	NULL
a	NULL
regulatory	NULL
role	NULL
in	NULL
B-cell-specific	NULL
«	NULL
transcription	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
hypothesis	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
induced	NULL
in	NULL
pre-B	NULL
cells	NULL
by	NULL
bacterial	NULL
lipopolysaccharide	NULL
or	NULL
phorbol	NULL
ester	NULL
in	NULL
concert	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
x	NULL
light	NULL
chain	NULL
gene	NULL
transcription	NULL
(	NULL
3	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
in	NULL
HeLa	NULL
or	NULL
T-cell	NULL
lymphoma	NULL
cells	NULL
phorbol	NULL
ester	NULL
simultaneously	NULL
induces	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
and	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
transcription	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

An	NULL
NF-	NULL
«	NULL
B-binding	NULL
site	NULL
exists	NULL
not	NULL
only	NULL
in	NULL
the	NULL
x	NULL
enhancer	NULL
but	NULL
also	NULL
in	NULL
the	NULL
enhancers	NULL
of	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
(	NULL
11	NULL
)	NULL
,	NULL
cyto-megalovirus	NULL
(	NULL
12	NULL
)	NULL
,	NULL
HIV-1	NULL
(	NULL
13	NULL
)	NULL
,	NULL
and	NULL
B	NULL
,	NULL
-microglobulin	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
motif	NULL
in	NULL
the	NULL
SV40	NULL
enhancer	NULL
decreased	NULL
the	NULL
enhancer	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
15	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
involved	NULL
in	NULL
regulating	NULL
the	NULL
transcription	NULL
of	NULL
many	NULL
genes	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
x	NULL
light	NULL
chain	NULL
genes	NULL
.	NULL

To	NULL
establish	NULL
its	NULL
role	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
and	NULL
,	NULL
ultimately	NULL
,	NULL
to	NULL
analyze	NULL
structure-function	NULL
relationships	NULL
,	NULL
we	NULL
have	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
a	NULL
mature	NULL
B-cell	NULL
line	NULL
and	NULL
tested	NULL
its	NULL
functional	NULL
(	NULL
transcriptional	NULL
)	NULL
activity	NULL
on	NULL
the	NULL
HIV-1	NULL
promoter	NULL
in	NULL
vitro	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Recombinant	NULL
Plasmids	NULL
.	NULL

A	NULL
475-base-pair	NULL
(	NULL
bp	NULL
)	NULL
EcoRI	NULL
fragment	NULL
containing	NULL
x-enhancer	NULL
sequences	NULL
from	NULL
position	NULL
3689	NULL
to	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

4700	NULL
position	NULL
4163	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
was	NULL
excised	NULL
from	NULL
plasmid	NULL
pLX40P.1	NULL
(	NULL
18	NULL
)	NULL
,	NULL
subcloned	NULL
into	NULL
plasmid	NULL
pUC13	NULL
,	NULL
and	NULL
used	NULL
as	NULL
one	NULL
probe	NULL
(	NULL
kindly	NULL
donated	NULL
by	NULL
R.	NULL
Currie	NULL
,	NULL
Rockefeller	NULL
University	NULL
,	NULL
New	NULL
York	NULL
)	NULL
.	NULL

An	NULL
Xho	NULL
I-EcoRI	NULL
fragment	NULL
containing	NULL
HIV-1	NULL
sequence	NULL
from	NULL
position	NULL
-167	NULL
to	NULL
position	NULL
+80	NULL
fused	NULL
to	NULL
the	NULL
bacterial	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
fragment	NULL
(	NULL
HirndIII-EcoRI	NULL
)	NULL
of	NULL
p167	NULL
(	NULL
13	NULL
)	NULL
was	NULL
subcloned	NULL
into	NULL
pUC13	NULL
(	NULL
pXRIII	NULL
,	NULL
kindly	NULL
provided	NULL
by	NULL
M.	NULL
Sawadogo	NULL
,	NULL
Rockefeller	NULL
University	NULL
)	NULL
and	NULL
used	NULL
as	NULL
a	NULL
second	NULL
probe	NULL
.	NULL

pU3R/-121	NULL
and	NULL
pU3R/-57	NULL
(	NULL
13	NULL
)	NULL
were	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
C.	NULL
Rosen	NULL
(	NULL
Roche	NULL
Institute	NULL
)	NULL
and	NULL
were	NULL
used	NULL
as	NULL
templates	NULL
for	NULL
in	NULL
vitro	NULL
transcription	NULL
.	NULL

Oligonucleotides	NULL
and	NULL
Affinity	NULL
Column	NULL
.	NULL

A	NULL
specific	NULL
oligonucleotide	NULL
that	NULL
forms	NULL
the	NULL
recognition	NULL
site	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
contains	NULL
a	NULL
6-nucleotide	NULL
5'-end	NULL
extension	NULL
was	NULL
prepared	NULL
by	NULL
annealing	NULL
the	NULL
following	NULL
chemically	NULL
synthesized	NULL
oligonucleotides	NULL
:	NULL
A	NULL
(	NULL
§-GGATCCTCAACAGAGGGGACTTTCCGAG-GCCA-3	NULL
``	NULL
)	NULL
and	NULL
B	NULL
(	NULL
5-GGATCCTGGCCTCGGAAAGTCCC-CTCTGTTGA-3	NULL
'	NULL
)	NULL
.	NULL

A	NULL
mutant	NULL
oligonucleotide	NULL
that	NULL
contains	NULL
a	NULL
1-bp	NULL
change	NULL
(	NULL
bases	NULL
in	NULL
boldface	NULL
letters	NULL
)	NULL
in	NULL
the	NULL
recognition	NULL
site	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
prepared	NULL
from	NULL
synthesized	NULL
oligonucleotides	NULL
:	NULL
C	NULL
(	NULL
5-GGATCCTCAACAGAGGCGACTTTCCGAGGCCA-3	NULL
'	NULL
)	NULL
and	NULL
D	NULL
(	NULL
5-GGATCCTGGCCTCGGAAAGTCGCCTCT-GTTGA-3	NULL
'	NULL
)	NULL
.	NULL

CNBr-activated	NULL
Sepharose	NULL
CL-4B	NULL
(	NULL
Pharmacia	NULL
)	NULL
was	NULL
coupled	NULL
with	NULL
the	NULL
double-stranded	NULL
oligonucleotides	NULL
as	NULL
described	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Approximately	NULL
0.25	NULL
mg	NULL
of	NULL
DNA	NULL
was	NULL
coupled	NULL
per	NULL
ml	NULL
of	NULL
matrix	NULL
.	NULL

Purification	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

The	NULL
preparation	NULL
of	NULL
Namalwa-cell	NULL
nuclear	NULL
extracts	NULL
and	NULL
the	NULL
chromatographic	NULL
buffers	NULL
BC	NULL
and	NULL
C	NULL
,	NULL
with	NULL
dithiothreitol	NULL
and	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
were	NULL
as	NULL
described	NULL
(	NULL
19	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
monitored	NULL
with	NULL
the	NULL
gel	NULL
retardation	NULL
assay	NULL
by	NULL
using	NULL
an	NULL
end-labeled	NULL
Dde	NULL
I-Sau3Al	NULL
fragment	NULL
(	NULL
positions	NULL
3886-3973	NULL
)	NULL
from	NULL
the	NULL
x	NULL
enhancer	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

The	NULL
first	NULL
two	NULL
steps	NULL
of	NULL
the	NULL
purification	NULL
were	NULL
as	NULL
described	NULL
for	NULL
octamer-binding	NULL
transcription	NULL
factor	NULL
2	NULL
,	NULL
except	NULL
that	NULL
a	NULL
typical	NULL
purification	NULL
involved	NULL
150	NULL
ml	NULL
of	NULL
Namalwa-cell	NULL
nuclear	NULL
extract	NULL
(	NULL
900	NULL
mg	NULL
of	NULL
protein	NULL
,	NULL
from	NULL
6	NULL
x	NULL
10	NULL
``	NULL
nuclei	NULL
)	NULL
and	NULL
slightly	NULL
larger	NULL
DEAE-cellulose	NULL
(	NULL
50	NULL
m	NULL
!	NULL
)	NULL

and	NULL
Bio-Rex	NULL
70	NULL
(	NULL
80	NULL
ml	NULL
,	NULL
equilibrated	NULL
with	NULL
buffer	NULL
BC/100	NULL
mM	NULL
KCI	NULL
)	NULL
columns	NULL
.	NULL

Active	NULL
fractions	NULL
(	NULL
170	NULL
mM-300	NULL
mM	NULL
KCI	NULL
)	NULL
from	NULL
the	NULL
Bio-Rex	NULL
70	NULL
column	NULL
were	NULL
pooled	NULL
,	NULL
dialyzed	NULL
to	NULL
100	NULL
mM	NULL
KCl	NULL
,	NULL
and	NULL
loaded	NULL
onto	NULL
a	NULL
10-ml	NULL
single-stranded	NULL
DNA-agarose	NULL
column	NULL
(	NULL
Pharmacia	NULL
)	NULL
equilibrated	NULL
in	NULL
buffer	NULL
BC/100	NULL
mM	NULL
KCI/0.03	NULL
%	NULL
Nonidet	NULL
P-40	NULL
(	NULL
NP-40	NULL
)	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
eluted	NULL
with	NULL
a	NULL
S5-column-volume	NULL
gradient	NULL
(	NULL
100-800	NULL
mM	NULL
KCI	NULL
)	NULL
in	NULL
the	NULL
same	NULL
buffer	NULL
.	NULL

Active	NULL
fractions	NULL
(	NULL
150	NULL
mM-350	NULL
mM	NULL
KCI	NULL
)	NULL
were	NULL
pooled	NULL
,	NULL
dialyzed	NULL
against	NULL
buffer	NULL
BC	NULL
containing	NULL
0.05	NULL
%	NULL
NP-40	NULL
to	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
and	NULL
loaded	NULL
onto	NULL
a	NULL
0.6-ml	NULL
specific-oligonucleotide-Sepharose	NULL
column	NULL
equilibrated	NULL
with	NULL
the	NULL
same	NULL
buffer	NULL
.	NULL

After	NULL
washing	NULL
with	NULL
buffer	NULL
BC/190	NULL
mM	NULL
KCI1/0.05	NULL
%	NULL
NP-40	NULL
,	NULL
bound	NULL
materials	NULL
were	NULL
eluted	NULL
with	NULL
buffer	NULL
BC/350	NULL
mM	NULL
KCI/0.05	NULL
%	NULL
NP-40	NULL
.	NULL

Activity-containing	NULL
fractions	NULL
were	NULL
combined	NULL
,	NULL
diluted	NULL
with	NULL
buffer	NULL
BC/0.05	NULL
%	NULL
NP-40	NULL
to	NULL
Abbreviations	NULL
:	NULL
HIV	NULL
,	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
;	NULL
SV40	NULL
,	NULL
simian	NULL
virus	NULL
40	NULL
;	NULL
NP-40	NULL
,	NULL
Nonidet	NULL
P-40	NULL
;	NULL
BrdUrd	NULL
,	NULL
bromodeoxyuridine	NULL
.	NULL

Biochemistry	NULL
:	NULL
Kawakami	NULL
et	NULL
al	NULL
.	NULL

a	NULL
final	NULL
concentration	NULL
of	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
and	NULL
loaded	NULL
onto	NULL
a	NULL
0.6-ml	NULL
mutant-oligonucleotide-Sepharose	NULL
column	NULL
equilibrated	NULL
with	NULL
buffer	NULL
BC/100	NULL
mM	NULL
KCI/0.05	NULL
%	NULL
NP-40	NULL
.	NULL

The	NULL
column	NULL
was	NULL
washed	NULL
with	NULL
10	NULL
column	NULL
volumes	NULL
of	NULL
the	NULL
same	NULL
buffer	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
eluted	NULL
with	NULL
buffer	NULL
BC/190	NULL
mM	NULL
KCI/0.05	NULL
%	NULL
NP-40	NULL
.	NULL

Activity-containing	NULL
fractions	NULL
were	NULL
combined	NULL
and	NULL
diluted	NULL
with	NULL
buffer	NULL
BC/0.05	NULL
%	NULL
NP-40	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
100	NULL
mM	NULL
KCI	NULL
.	NULL

After	NULL
addition	NULL
of	NULL
herring	NULL
testis	NULL
DNA	NULL
to	NULL
200	NULL
ug/ml	NULL
,	NULL
the	NULL
solution	NULL
was	NULL
incubated	NULL
at	NULL
0°C	NULL
for	NULL
1	NULL
hr	NULL
and	NULL
then	NULL
loaded	NULL
onto	NULL
a	NULL
0.6-ml	NULL
specific-oligonucleotide-Sepharose	NULL
column	NULL
equilibrated	NULL
with	NULL
buffer	NULL
BC/100	NULL
mM	NULL
KCI1/0.5	NULL
%	NULL
NP-40/herring	NULL
DNA	NULL
(	NULL
200	NULL
ug/ml	NULL
)	NULL
.	NULL

The	NULL
column	NULL
was	NULL
washed	NULL
with	NULL
buffer	NULL
BC/190	NULL
mM	NULL
KCI/0.05	NULL
%	NULL
NP-40	NULL
,	NULL
and	NULL
NF-kB	NULL
was	NULL
eluted	NULL
with	NULL
buffer	NULL
BC/350	NULL
mM	NULL
KCI/0.05	NULL
%	NULL
NP-40	NULL
.	NULL

The	NULL
eluted	NULL
material	NULL
was	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
and	NULL
stored	NULL
at	NULL
-70°C	NULL
.	NULL

UV	NULL
Crosslinking	NULL
.	NULL

All	NULL
the	NULL
procedures	NULL
were	NULL
essentially	NULL
as	NULL
described	NULL
by	NULL
Wu	NULL
et	NULL
al	NULL
.	NULL

(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
bromodeoxyuridine	NULL
(	NULL
Brd-Urd	NULL
)	NULL
-substituted	NULL
oligonucleotide	NULL
probe	NULL
was	NULL
prepared	NULL
by	NULL
annealing	NULL
oligonucleotide	NULL
A	NULL
(	NULL
for	NULL
the	NULL
specific	NULL
probe	NULL
)	NULL
or	NULL
C	NULL
(	NULL
for	NULL
the	NULL
mutant	NULL
probe	NULL
)	NULL
with	NULL
the	NULL
complementary	NULL
primer	NULL
5'-TGGCCTCGGA-3	NULL
'	NULL
and	NULL
filling	NULL
in	NULL
with	NULL
the	NULL
Kienow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
,	NULL
[	NULL
>	NULL
P	NULL
]	NULL
dATP	NULL
,	NULL
[	NULL
>	NULL
P	NULL
]	NULL
JdCTP	NULL
,	NULL
dGTP	NULL
,	NULL
and	NULL
a	NULL
1:1	NULL
ratio	NULL
of	NULL
dTTP/BrdUrd	NULL
.	NULL

One	NULL
microliter	NULL
of	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
fraction	NULL
was	NULL
incubated	NULL
with	NULL
BrdUrd-substituted	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
competitors	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
in	NULL
10	NULL
ul	NULL
of	NULL
gel-retardation-assay	NULL
buffer	NULL
(	NULL
19	NULL
)	NULL
at	NULL
30°C	NULL
for	NULL
15	NULL
min	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
placed	NULL
5	NULL
cm	NULL
from	NULL
a	NULL
UV	NULL
lamp	NULL
(	NULL
1600	NULL
uW/cm	NULL
,	NULL
260	NULL
nm	NULL
)	NULL
and	NULL
irradiated	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

One	NULL
microliter	NULL
of	NULL
a	NULL
solution	NULL
of	NULL
120	NULL
mM	NULL
CaCl	NULL
,	NULL
and	NULL
24	NULL
mM	NULL
MgCl	NULL
;	NULL
and	NULL
1	NULL
ul	NULL
of	NULL
a	NULL
mixture	NULL
of	NULL
DNase	NULL
I	NULL
and	NULL
micrococcal	NULL
nuclease	NULL
[	NULL
2.5	NULL
units/ul	NULL
and	NULL
0.2	NULL
unit/ul	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
5	NULL
mM	NULL
TrisHC	NULL
]	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
containing	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
35	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol	NULL
,	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
50	NULL
ng/ul1	NULL
)	NULL
,	NULL
and	NULL
10	NULL
mM	NULL
CaCl	NULL
;	NULL
]	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
complex	NULL
was	NULL
digested	NULL
for	NULL
25	NULL
min	NULL
at	NULL
30°C	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
terminated	NULL
with	NULL
1	NULL
ul	NULL
of	NULL
0.25	NULL
M	NULL
EGTA	NULL
.	NULL

After	NULL
addition	NULL
of	NULL
3	NULL
ul	NULL
of	NULL
5x	NULL
NaDodSO	NULL
,	NULL
sample	NULL
buffer	NULL
,	NULL
the	NULL
sample	NULL
was	NULL
boiled	NULL
for	NULL
2	NULL
min	NULL
,	NULL
electrophoresed	NULL
on	NULL
a	NULL
10	NULL
%	NULL
polyacrylamide/	NULL
NaDodSO	NULL
,	NULL
gel	NULL
(	NULL
21	NULL
)	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

In	NULL
Vitro	NULL
Transcription	NULL
.	NULL

Transcription	NULL
reaction	NULL
mixtures	NULL
(	NULL
30	NULL
pl	NULL
)	NULL
contained	NULL
20	NULL
mM	NULL
Hepes	NULL
(	NULL
pH	NULL
8.4	NULL
)	NULL
,	NULL
70	NULL
mM	NULL
KCI	NULL
,	NULL
3	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.6	NULL
mM	NULL
ATP	NULL
,	NULL
0.6	NULL
mM	NULL
CTP	NULL
,	NULL
and	NULL
0.6	NULL
mM	NULL
UTP	NULL
,	NULL
0.03	NULL
mM	NULL
[	NULL
°P	NULL
]	NULL
JGTP	NULL
(	NULL
0.1	NULL
mCi/ml	NULL
;	NULL
1	NULL
Ci	NULL
=	NULL
37	NULL
GBq	NULL
)	NULL
,	NULL
template	NULL
DNA	NULL
(	NULL
50	NULL
ng	NULL
)	NULL
,	NULL
and	NULL
8.4	NULL
Ll	NULL
of	NULL
HeLa-cell	NULL
nuclear	NULL
extract	NULL
(	NULL
~60	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
.	NULL

After	NULL
incubating	NULL
1	NULL
hr	NULL
at	NULL
30°C	NULL
,	NULL
run-off	NULL
transcripts	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
denaturing	NULL
4.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

RESULTS	NULL
Purification	NULL
of	NULL
Enhancer-Binding	NULL
Protein	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Our	NULL
purification	NULL
scheme	NULL
involved	NULL
six	NULL
chromatographic	NULL
steps	NULL
.	NULL

These	NULL
included	NULL
passage	NULL
through	NULL
DE	NULL
52	NULL
at	NULL
a	NULL
high	NULL
salt	NULL
concentration	NULL
(	NULL
to	NULL
remove	NULL
RNA	NULL
and	NULL
nucleoprotein	NULL
complexes	NULL
)	NULL
,	NULL
chromatography	NULL
on	NULL
Bio-Rex	NULL
70	NULL
and	NULL
on	NULL
single-stranded	NULL
DNA-agarose	NULL
,	NULL
and	NULL
chromatography	NULL
on	NULL
specific-oligonucleotide	NULL
columns	NULL
(	NULL
20	NULL
)	NULL
containing	NULL
the	NULL
«	NULL
-enhancer	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
[	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
nonspecific	NULL
DNA	NULL
(	NULL
22	NULL
)	NULL
]	NULL
or	NULL
a	NULL
mutated	NULL
NF-KB	NULL
site	NULL
(	NULL
which	NULL
reduced	NULL
NF-	NULL
«	NULL
B	NULL
affinity	NULL
by	NULL
a	NULL
factor	NULL
of	NULL
>	NULL
100	NULL
)	NULL
.	NULL

Omission	NULL
of	NULL
any	NULL
one	NULL
of	NULL
the	NULL
three	NULL
oligonucleotide	NULL
column	NULL
steps	NULL
resulted	NULL
in	NULL
several	NULL
contaminating	NULL
protein	NULL
bands	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Fractions	NULL
from	NULL
the	NULL
final	NULL
column	NULL
were	NULL
assayed	NULL
in	NULL
the	NULL
gel	NULL
retardation	NULL
assay	NULL
and	NULL
by	NULL
NaDodSO	NULL
,	NULL
/polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

In	NULL
those	NULL
fractions	NULL
containing	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
two	NULL
major	NULL
bands	NULL
of	NULL
68	NULL
kDa	NULL
and	NULL
51	NULL
kDa	NULL
were	NULL
detected	NULL
on	NULL
polyacrylamide	NULL
gels	NULL
by	NULL
Coomassie	NULL
stain	NULL
.	NULL

Within	NULL
the	NULL
sensitivity	NULL
limits	NULL
of	NULL
this	NULL
analysis	NULL
,	NULL
only	NULL
the	NULL
51-kDa	NULL
protein	NULL
correlated	NULL
in	NULL
elution	NULL
position	NULL
with	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Silver	NULL
staining	NULL
of	NULL
gels	NULL
containing	NULL
the	NULL
peak	NULL
fraction	NULL
showed	NULL
the	NULL
same	NULL
(	NULL
major	NULL
)	NULL
51-kDa	NULL
and	NULL
68-kDa	NULL
poly-peptides	NULL
and	NULL
only	NULL
one	NULL
additional	NULL
band	NULL
of	NULL
any	NULL
significance	NULL
at	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
(	NULL
1988	NULL
)	NULL
4701	NULL
45	NULL
kDa	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Table	NULL
1	NULL
summarizes	NULL
the	NULL
purification	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
Namalwa-cell	NULL
nuclear	NULL
extract	NULL
.	NULL

The	NULL
overall	NULL
purification	NULL
and	NULL
the	NULL
yield	NULL
of	NULL
the	NULL
specific	NULL
DNA	NULL
binding	NULL
activity	NULL
were	NULL
~4000-fold	NULL
and	NULL
0.8	NULL
%	NULL
,	NULL
respectively	NULL
.	NULL

Specificity	NULL
of	NULL
the	NULL
Purified	NULL
NF-B	NULL
Binding	NULL
Complexes	NULL
.	NULL

In	NULL
a	NULL
gel	NULL
retardation	NULL
assay	NULL
with	NULL
the	NULL
«	NULL
light	NULL
chain	NULL
enhancer	NULL
probe	NULL
(	NULL
an	NULL
88-bp	NULL
end-labeled	NULL
Dde	NULL
I-Sau3AI	NULL
fragment	NULL
)	NULL
,	NULL
purified	NULL
NF-kB	NULL
formed	NULL
four	NULL
distinct	NULL
complexes	NULL
.	NULL

By	NULL
using	NULL
other	NULL
probes	NULL
such	NULL
as	NULL
the	NULL
Dde	NULL
I-Sau96l	NULL
!	NULL

fragment	NULL
(	NULL
positions	NULL
3886-4012	NULL
)	NULL
from	NULL
the	NULL
x	NULL
enhancer	NULL
or	NULL
Xba	NULL
I-Pvu	NULL
II	NULL
(	NULL
position	NULL
-19	NULL
)	NULL
fragment	NULL
of	NULL
the	NULL
HIV-1	NULL
promoter	NULL
,	NULL
similar	NULL
complexes	NULL
were	NULL
formed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
these	NULL
complexes	NULL
designated	NULL
C1	NULL
,	NULL
C2	NULL
,	NULL
and	NULL
C3	NULL
(	NULL
a	NULL
doublet	NULL
)	NULL
,	NULL
was	NULL
inhibited	NULL
by	NULL
a	NULL
specific	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
but	NULL
not	NULL
by	NULL
an	NULL
octamer-containing	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
which	NULL
readily	NULL
inhibited	NULL
the	NULL
binding	NULL
of	NULL
a	NULL
purified	NULL
octamer-binding	NULL
transcription	NULL
factor	NULL
to	NULL
the	NULL
octamer	NULL
motif	NULL
(	NULL
19	NULL
)	NULL
.	NULL

A	NULL
further	NULL
analysis	NULL
of	NULL
the	NULL
sites	NULL
of	NULL
interaction	NULL
in	NULL
complexes	NULL
C1	NULL
,	NULL
C2	NULL
,	NULL
and	NULL
C3	NULL
is	NULL
presented	NULL
below	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-Binding	NULL
Protein	NULL
by	NULL
UV	NULL
Crosslinking	NULL
.	NULL

The	NULL
co-elution	NULL
of	NULL
the	NULL
51-kDa	NULL
protein	NULL
band	NULL
with	NULL
the	NULL
specific	NULL
NF-	NULL
«	NULL
B-DNA	NULL
binding	NULL
activity	NULL
(	NULL
above	NULL
)	NULL
suggested	NULL
that	NULL
it	NULL
was	NULL
responsible	NULL
for	NULL
the	NULL
site-specific	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
activity	NULL
of	NULL
the	NULL
purified	NULL
fraction	NULL
.	NULL

To	NULL
confirm	NULL
this	NULL
,	NULL
we	NULL
used	NULL
the	NULL
UV-crosslinking	NULL
procedure	NULL
that	NULL
was	NULL
employed	NULL
by	NULL
Wu	NULL
et	NULL
al	NULL
.	NULL

(	NULL
20	NULL
)	NULL
to	NULL
identify	NULL
a	NULL
purified	NULL
Drosophila	NULL
heat	NULL
shock	NULL
activator	NULL
protein	NULL
.	NULL

The	NULL
photoaffinity	NULL
labeling	NULL
probe	NULL
was	NULL
prepared	NULL
from	NULL
specific	NULL
oligonucleotide	NULL
A	NULL
or	NULL
mutant	NULL
oligonucleotide	NULL
C.	NULL
BrdUrd	NULL
substitution	NULL
did	NULL
not	NULL
change	NULL
the	NULL
specific	NULL
binding	NULL
activity	NULL
as	NULL
measured	NULL
in	NULL
the	NULL
gel	NULL
retardation	NULL
assay	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
after	NULL
binding	NULL
,	NULL
UV	NULL
crosslinking	NULL
,	NULL
nuclease	NULL
digestion	NULL
,	NULL
and	NULL
NaDodSO	NULL
,	NULL
/polyacrylamide	NULL
gel	NULL
electrophore-sis	NULL
,	NULL
the	NULL
51-kDa	NULL
protein	NULL
was	NULL
labeled	NULL
by	NULL
°°P	NULL
transfer	NULL
from	NULL
the	NULL
specific	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Controls	NULL
with	NULL
the	NULL
[	NULL
°P	NULL
]	NULL
BrdUrd-labeled	NULL
mutant-oligonucleotide	NULL
probe	NULL
showed	NULL
no	NULL
labeled	NULL
band	NULL
(	NULL
lanes	NULL
8-10	NULL
)	NULL
.	NULL

In	NULL
competition	NULL
A	NULL
s	NULL
€	NULL
7	NULL
B	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
R	NULL
@	NULL
.	NULL

-	NULL
116	NULL
-84	NULL
u.	NULL
s=	NULL
-CI	NULL
@	NULL
»	NULL
_	NULL
;	NULL
;	NULL
5	NULL
.	NULL

~NCZ	NULL
7	NULL
}	NULL
C3	NULL
-36.5	NULL
-26.6	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

(	NULL
4	NULL
)	NULL
NaDodSO	NULL
,	NULL
/polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
of	NULL
affinity-purified	NULL
NF-	NULL
«	NULL
B	NULL
fractions	NULL
.	NULL

Forty	NULL
microliters	NULL
of	NULL
the	NULL
input	NULL
to	NULL
the	NULL
final	NULL
affinity	NULL
column	NULL
and	NULL
80	NULL
al	NULL
of	NULL
fraction	NULL
17	NULL
were	NULL
precipitated	NULL
with	NULL
10	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
trichloroacetic	NULL
acid	NULL
,	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
a	NULL
NaDodSO	NULL
,	NULL
gel	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
silver	NULL
.	NULL

Positions	NULL
of	NULL
molecular	NULL
size	NULL
markers	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Gel	NULL
retardation/oligonucleotide	NULL
competition	NULL
analysis	NULL
of	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
the	NULL
«	NULL
enhancer	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
19	NULL
)	NULL
with	NULL
10	NULL
fmol	NULL
of	NULL
end-labeled	NULL
probe	NULL
(	NULL
Dde	NULL
I-Sau3Al	NULL
fragment	NULL
)	NULL
in	NULL
a	NULL
20-ul	NULL
reaction	NULL
mixture	NULL
.	NULL

The	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
fraction	NULL
(	NULL
1	NULL
wl	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
probe	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
competitor	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B-sequence-containing	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
or	NULL
an	NULL
octamer-sequence-containing	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
added	NULL
at	NULL
a	NULL
50-fold	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
or	NULL
20-fold	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
)	NULL
molar	NULL
excess	NULL
relative	NULL
to	NULL
the	NULL
probe	NULL
.	NULL

C1	NULL
,	NULL
C2	NULL
,	NULL
and	NULL
C3	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
complexes	NULL
observed	NULL
.	NULL

4702	NULL
Biochemistry	NULL
:	NULL
Kawakami	NULL
et	NULL
al	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
(	NULL
1988	NULL
)	NULL
Table	NULL
1	NULL
.	NULL

-	NULL
Purification	NULL
of	NULL
the	NULL
enhancer-binding	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
Total	NULL
Total	NULL
Specific	NULL
protein	NULL
,	NULL
activity	NULL
,	NULL
activity	NULL
,	NULL
Fold	NULL
Yield	NULL
,	NULL
Fraction	NULL
mg	NULL
units	NULL
units/mg	NULL
purification	NULL
%	NULL
Nuclear	NULL
extract	NULL
900	NULL
120,000	NULL
130	NULL
100	NULL
DE	NULL
52	NULL
850	NULL
137,000	NULL
160	NULL
1.2	NULL
114	NULL
Bio-Rex	NULL
70	NULL
123	NULL
31,000	NULL
252	NULL
1.6	NULL
26	NULL
Single-stranded	NULL
DNA-agarose	NULL
24	NULL
15,000	NULL
625	NULL
2.5	NULL
12.5	NULL
Specific	NULL
oligo-Sepharose	NULL
(	NULL
first	NULL
)	NULL
0.37	NULL
4,000	NULL
10,800	NULL
17.3	NULL
3.0	NULL
Mutant	NULL
oligo-Sepharose	NULL
0.092	NULL
2,800	NULL
30,400	NULL
2.8	NULL
2.3	NULL
Specific	NULL
oligo-Sepharose	NULL
(	NULL
second	NULL
)	NULL
0.002	NULL
1,000	NULL
500,000	NULL
16.5	NULL
0.8	NULL
For	NULL
specific	NULL
activity	NULL
,	NULL
one	NULL
unit	NULL
of	NULL
binding	NULL
activity	NULL
is	NULL
the	NULL
amount	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
that	NULL
,	NULL
under	NULL
standard	NULL
gel-retardation-assay	NULL
conditions	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1.5	NULL
ug	NULL
of	NULL
poly	NULL
[	NULL
d	NULL
(	NULL
I-C	NULL
)	NULL
d	NULL
(	NULL
I-C	NULL
)	NULL
]	NULL
and	NULL
20	NULL
fmol	NULL
of	NULL
probe	NULL
,	NULL
retards	NULL
1	NULL
fmol	NULL
of	NULL
end-labeled	NULL
probe	NULL
.	NULL

Oligo	NULL
,	NULL
oligonucleotide	NULL
.	NULL

experiments	NULL
an	NULL
unlabeled	NULL
specific	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
a	NULL
k-enhancer	NULL
fragment	NULL
containing	NULL
the	NULL
NF-	NULL
«	NULL
B-binding	NULL
sequence	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
abolished	NULL
the	NULL
signal	NULL
,	NULL
whereas	NULL
neither	NULL
the	NULL
mutant	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
nor	NULL
pUC19	NULL
DNA	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
did	NULL
so	NULL
.	NULL

Omission	NULL
of	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
protein	NULL
from	NULL
the	NULL
reaction	NULL
mixture	NULL
also	NULL
failed	NULL
to	NULL
produce	NULL
any	NULL
signal	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Omission	NULL
of	NULL
the	NULL
DNase	NULL
treatment	NULL
resulted	NULL
in	NULL
a	NULL
labeled	NULL
band	NULL
remaining	NULL
at	NULL
the	NULL
position	NULL
of	NULL
a	NULL
60-kDa	NULL
protein	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
undigested	NULL
32-bp	NULL
probe	NULL
remained	NULL
covalently	NULL
attached	NULL
to	NULL
the	NULL
51-kDa	NULL
protein	NULL
.	NULL

Interactions	NULL
of	NULL
Purified	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
the	NULL
x	NULL
Enhancer	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
and	NULL
methylation-interference	NULL
experiments	NULL
were	NULL
performed	NULL
on	NULL
the	NULL
C1	NULL
,	NULL
C2	NULL
,	NULL
and	NULL
C3	NULL
complexes	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
the	NULL
DNase-footprint	NULL
analysis	NULL
of	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
9	NULL
nucleotides	NULL
of	NULL
the	NULL
upper	NULL
strand	NULL
and	NULL
13	NULL
nucleotides	NULL
of	NULL
the	NULL
lower	NULL
strand	NULL
were	NULL
protected	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
guanine	NULL
contacts	NULL
in	NULL
this	NULL
protected	NULL
region	NULL
the	NULL
methylation-interference	NULL
analysis	NULL
was	NULL
performed	NULL
.	NULL

Methylation	NULL
of	NULL
six	NULL
of	NULL
the	NULL
guanines	NULL
(	NULL
marked	NULL
with	NULL
arrows	NULL
)	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B-binding	NULL
sequence	NULL
interfered	NULL
with	NULL
the	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
C1	NULL
and	NULL
C2	NULL
)	NULL
.	NULL

Corresponding	NULL
cleavage	NULL
enhancement	NULL
at	NULL
the	NULL
positions	NULL
of	NULL
these	NULL
six	NULL
guanines	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
free	NULL
probe	NULL
(	NULL
lane	NULL
F	NULL
)	NULL
.	NULL

These	NULL
observed	NULL
enhancements	NULL
(	NULL
in	NULL
the	NULL
free	NULL
probe	NULL
pool	NULL
)	NULL
with	NULL
probes	NULL
methylated	NULL
at	NULL
these	NULL
positions	NULL
were	NULL
expected	NULL
since	NULL
only	NULL
=~40	NULL
%	NULL
of	NULL
the	NULL
probe	NULL
was	NULL
uncomplexed	NULL
in	NULL
this	NULL
experiment	NULL
.	NULL

The	NULL
methylation	NULL
interference	NULL
and	NULL
DNase	NULL
protection	NULL
results	NULL
are	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

3C	NULL
.	NULL

Transcriptional	NULL
Activity	NULL
of	NULL
the	NULL
Purified	NULL
NF-xB	NULL
.	NULL

Although	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
purified	NULL
with	NULL
the	NULL
x-enhancer	NULL
fragment	NULL
as	NULL
probe	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
a	NULL
x	NULL
enhancer-dependent	NULL
in	NULL
vitro	NULL
transcription	NULL
I-22	NULL
3	NULL
4	NULL
50°06	NULL
7	NULL
8	NULL
9	NULL
10	NULL
116	NULL
-84	NULL
,	NULL
-58	NULL
-	NULL
#	NULL
#	NULL
36.5	NULL
26.6	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Identification	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
protein	NULL
by	NULL
UV	NULL
crosslinking	NULL
.	NULL

The	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
fraction	NULL
(	NULL
1	NULL
wl	NULL
)	NULL
was	NULL
incubated	NULL
with	NULL
BrdUrd-substituted	NULL
specific-oligonucleotide	NULL
probe	NULL
(	NULL
lanes	NULL
2-7	NULL
)	NULL
or	NULL
with	NULL
BrdUrd-substituted	NULL
mutant-oligonucleotide	NULL
probe	NULL
(	NULL
lanes	NULL
8-10	NULL
)	NULL
,	NULL
UV	NULL
crosslinked	NULL
,	NULL
digested	NULL
with	NULL
the	NULL
nuclease	NULL
mixture	NULL
,	NULL
and	NULL
analyzed	NULL
on	NULL
an	NULL
NaDodSO	NULL
,	NULL
/polyacrylamide	NULL
gel	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
no	NULL
NF-	NULL
«	NULL
B	NULL
fraction	NULL
added	NULL
;	NULL
3	NULL
and	NULL
9	NULL
,	NULL
5	NULL
ng	NULL
(	NULL
100-fold	NULL
molar	NULL
excess	NULL
)	NULL
of	NULL
specific	NULL
oligonucleotide	NULL
;	NULL
4	NULL
and	NULL
10	NULL
,	NULL
5	NULL
ng	NULL
of	NULL
mutant	NULL
oligonucleotide	NULL
;	NULL
5	NULL
,	NULL
45	NULL
ng	NULL
of	NULL
213-bp	NULL
Dde	NULL
I	NULL
fragment	NULL
of	NULL
the	NULL
x	NULL
enhancer	NULL
(	NULL
positions	NULL
3886-4098	NULL
)	NULL
;	NULL
6	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
pUC19	NULL
DNA	NULL
;	NULL
7	NULL
,	NULL
without	NULL
DNase	NULL
treatment	NULL
.	NULL

Molecular	NULL
size	NULL
markers	NULL
in	NULL
kDa	NULL
are	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
the	NULL
51-kDa	NULL
band	NULL
.	NULL

system	NULL
has	NULL
precluded	NULL
functional	NULL
analysis	NULL
of	NULL
this	NULL
enhancer	NULL
.	NULL

We	NULL
,	NULL
therefore	NULL
,	NULL
used	NULL
the	NULL
HIV-1	NULL
promoter	NULL
,	NULL
which	NULL
has	NULL
two	NULL
putative	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
in	NULL
the	NULL
enhancer	NULL
(	NULL
23	NULL
)	NULL
,	NULL
as	NULL
the	NULL
p	NULL
6	NULL
r	NULL
cicecs	NULL
o	NULL
F	NULL
oicecs	NULL
B	NULL
igor	NULL
1	NULL
``	NULL
8	NULL
%	NULL
3938	NULL
#	NULL
#	NULL
3950E	NULL
3939	NULL
i	NULL
I	NULL
is	NULL
ﬁ	NULL
4°	NULL
3946	NULL
&	NULL
41	NULL
...	NULL
Infedscacd	NULL
Lower	NULL
Upper	NULL
L	NULL
ower	NULL
Upper	NULL
Strand	NULL
Strand	NULL
Strand	NULL
©	NULL
.	NULL
'	NULL

Stand	NULL
C	NULL
3940	NULL
3950	NULL
\	NULL
A	NULL
AJ	NULL
I	NULL
AACAGAGGGGACTTTCCGAGGCCATCT	NULL
TTGTCTCCCCTGAAAGGCTCCGGTAGA	NULL
L222	NULL
222	NULL
&	NULL
AA	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
and	NULL
methylation-interference	NULL
analyses	NULL
of	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
the	NULL
x	NULL
enhancer	NULL
.	NULL

(	NULL
A	NULL
)	NULL
DNase	NULL
I	NULL
footprints	NULL
were	NULL
generated	NULL
with	NULL
a	NULL
5'-labeled	NULL
(	NULL
lower	NULL
strand	NULL
)	NULL
or	NULL
a	NULL
3'-labeled	NULL
(	NULL
upper	NULL
strand	NULL
)	NULL
Dde	NULL
I-Sau9	NULL
%	NULL
6l	NULL
fragment	NULL
(	NULL
positions	NULL
3886-4012	NULL
)	NULL
of	NULL
the	NULL
x	NULL
enhancer	NULL
.	NULL

The	NULL
80-4l	NULL
binding	NULL
reaction	NULL
mixtures	NULL
(	NULL
19	NULL
)	NULL
contained	NULL
40	NULL
fmol	NULL
of	NULL
probe	NULL
and	NULL
5	NULL
ul	NULL
of	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
but	NULL
no	NULL
poly	NULL
[	NULL
d	NULL
(	NULL
I-C	NULL
)	NULL
-d	NULL
(	NULL
I-C	NULL
)	NULL
]	NULL
.	NULL

After	NULL
30	NULL
min	NULL
at	NULL
30°C	NULL
,	NULL
16	NULL
pl	NULL
of	NULL
DNase	NULL
I	NULL
(	NULL
1	NULL
ug/ml	NULL
!	NULL
)	NULL

in	NULL
18	NULL
mM	NULL
MgCl	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
CaCl	NULL
,	NULL
was	NULL
added	NULL
and	NULL
incubated	NULL
40	NULL
sec	NULL
at	NULL
25°C	NULL
.	NULL

Reactions	NULL
were	NULL
stopped	NULL
with	NULL
1	NULL
ul	NULL
of	NULL
0.5	NULL
M	NULL
EDTA	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
analyzed	NULL
on	NULL
nondenaturing	NULL
gels	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Bands	NULL
corresponding	NULL
to	NULL
the	NULL
unretarded	NULL
probe	NULL
(	NULL
F	NULL
)	NULL
and	NULL
to	NULL
the	NULL
C1	NULL
,	NULL
C2	NULL
,	NULL
and	NULL
C3	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
were	NULL
excised	NULL
,	NULL
and	NULL
the	NULL
corresponding	NULL
DNAs	NULL
were	NULL
isolated	NULL
and	NULL
analyzed	NULL
on	NULL
an	NULL
8	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
urea	NULL
sequencing	NULL
gel	NULL
as	NULL
described	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Maxam-Gilbert	NULL
guanine	NULL
reaction	NULL
mixtures	NULL
were	NULL
in	NULL
adjacent	NULL
lanes	NULL
.	NULL

The	NULL
regions	NULL
of	NULL
protection	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Partially	NULL
methylated	NULL
5'-labeled	NULL
(	NULL
lower	NULL
strand	NULL
)	NULL
or	NULL
3'-labeled	NULL
Dde	NULL
I-Sau96	NULL
!	NULL

fragments	NULL
(	NULL
positions	NULL
3886-4012	NULL
)	NULL
were	NULL
prepared	NULL
and	NULL
used	NULL
for	NULL
gel	NULL
retardation	NULL
experiments	NULL
as	NULL
described	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Bands	NULL
corresponding	NULL
to	NULL
unretarded	NULL
probe	NULL
(	NULL
F	NULL
)	NULL
,	NULL
C1	NULL
,	NULL
and	NULL
C2	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
gel	NULL
after	NULL
autoradiography	NULL
.	NULL

Probe	NULL
DNA	NULL
(	NULL
lane	NULL
I	NULL
)	NULL
and	NULL
DNAs	NULL
recovered	NULL
from	NULL
the	NULL
gel	NULL
slices	NULL
were	NULL
cleaved	NULL
at	NULL
modified	NULL
guanines	NULL
and	NULL
resolved	NULL
on	NULL
an	NULL
8	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
urea	NULL
sequencing	NULL
gel	NULL
.	NULL

Guanine	NULL
positions	NULL
that	NULL
interfered	NULL
with	NULL
binding	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Summary	NULL
of	NULL
the	NULL
binding	NULL
data	NULL
.	NULL

Bars	NULL
above	NULL
and	NULL
below	NULL
the	NULL
x-enhancer	NULL
sequence	NULL
indicate	NULL
the	NULL
regions	NULL
protected	NULL
against	NULL
DNase	NULL
I	NULL
digestion	NULL
.	NULL

The	NULL
triangles	NULL
denote	NULL
guanines	NULL
whose	NULL
methylation	NULL
interferes	NULL
with	NULL
binding	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Biochemistry	NULL
:	NULL
Kawakami	NULL
et	NULL
al	NULL
.	NULL

template	NULL
for	NULL
in	NULL
vitro	NULL
transcription	NULL
.	NULL

These	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
are	NULL
responsible	NULL
for	NULL
inducibility	NULL
of	NULL
transcription	NULL
in	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
phorbol	NULL
esters	NULL
(	NULL
9	NULL
)	NULL
.	NULL

We	NULL
have	NULL
tested	NULL
two	NULL
kinds	NULL
of	NULL
deletion	NULL
mutants	NULL
.	NULL

pU3R/-121	NULL
contains	NULL
HIV-1	NULL
sequence	NULL
extending	NULL
from	NULL
position	NULL
-121	NULL
to	NULL
position	NULL
+80	NULL
and	NULL
includes	NULL
the	NULL
entire	NULL
promoter/enhancer	NULL
region	NULL
.	NULL

pU3R/-57	NULL
contains	NULL
sequence	NULL
from	NULL
position	NULL
-57	NULL
to	NULL
position	NULL
+80	NULL
and	NULL
lacks	NULL
the	NULL
two	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
(	NULL
from	NULL
position	NULL
-105	NULL
to	NULL
position	NULL
-82	NULL
)	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5C	NULL
and	NULL
ref	NULL
.	NULL

13	NULL
)	NULL
.	NULL

When	NULL
transcribed	NULL
in	NULL
HeLa	NULL
extracts	NULL
both	NULL
templates	NULL
generated	NULL
332-nucleotide	NULL
run-off	NULL
transcripts	NULL
corresponding	NULL
to	NULL
specific	NULL
initiation	NULL
at	NULL
the	NULL
in	NULL
vivo	NULL
cap	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
.	NULL

This	NULL
was	NULL
expected	NULL
since	NULL
these	NULL
templates	NULL
contain	NULL
a	NULL
``	NULL
TATA	NULL
box*	NULL
``	NULL
and	NULL
functional	NULL
SP1	NULL
site	NULL
(	NULL
10	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
affinity-purified	NULL
(	NULL
step	NULL
6	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
stimulated	NULL
transcription	NULL
from	NULL
the	NULL
-	NULL
121	NULL
template	NULL
~3-fold	NULL
(	NULL
quantitated	NULL
by	NULL
densitometry	NULL
of	NULL
the	NULL
x-ray	NULL
film	NULL
)	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
but	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
transcription	NULL
from	NULL
the	NULL
-57	NULL
template	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
activated	NULL
transcription	NULL
from	NULL
the	NULL
HIV-1	NULL
promoter	NULL
through	NULL
the	NULL
interaction	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
rather	NULL
than	NULL
in	NULL
a	NULL
nonspecific	NULL
manner	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
idea	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
the	NULL
HIV-1	NULL
promoter	NULL
.	NULL

Interaction	NULL
of	NULL
Purified	NULL
NF-B	NULL
with	NULL
the	NULL
HIV-1	NULL
Enhancer	NULL
Sites	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
with	NULL
an	NULL
HIV-1	NULL
enhancer	NULL
probe	NULL
and	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
revealed	NULL
complexes	NULL
(	NULL
C1	NULL
,	NULL
C2	NULL
,	NULL
and	NULL
C3	NULL
)	NULL
analogous	NULL
to	NULL
those	NULL
formed	NULL
with	NULL
the	NULL
xk	NULL
enhancer	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Of	NULL
the	NULL
two	NULL
putative	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
in	NULL
HIV-1	NULL
(	NULL
9	NULL
)	NULL
,	NULL
only	NULL
the	NULL
distal	NULL
binding	NULL
site	NULL
(	NULL
positions	NULL
-103	NULL
to	NULL
-~96	NULL
)	NULL
was	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
treatment	NULL
in	NULL
these	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Decreased	NULL
signals	NULL
indicative	NULL
of	NULL
methylation	NULL
interference	NULL
were	NULL
not	NULL
clearly	NULL
observed	NULL
in	NULL
complexed	NULL
probes	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lanes	NULL
C1	NULL
and	NULL
C2	NULL
)	NULL
,	NULL
but	NULL
enhanced	NULL
methylation	NULL
was	NULL
seen	NULL
in	NULL
the	NULL
free	NULL
probe	NULL
(	NULL
lane	NULL
F	NULL
,	NULL
see	NULL
above	NULL
)	NULL
,	NULL
suggesting	NULL
at	NULL
least	NULL
a	NULL
partial	NULL
interference	NULL
of	NULL
binding	NULL
when	NULL
one	NULL
of	NULL
these	NULL
six	NULL
guanine	NULL
residues	NULL
was	NULL
methylated	NULL
[	NULL
~25	NULL
%	NULL
of	NULL
the	NULL
probe	NULL
was	NULL
in	NULL
the	NULL
free	NULL
(	NULL
uncomplexed	NULL
)	NULL
form	NULL
in	NULL
this	NULL
experiment	NULL
]	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

DISCUSSION	NULL
To	NULL
understand	NULL
the	NULL
developmental	NULL
signals	NULL
that	NULL
lead	NULL
to	NULL
the	NULL
commitment	NULL
and	NULL
differentiation	NULL
of	NULL
lymphoid	NULL
cells	NULL
,	NULL
we	NULL
have	NULL
undertaken	NULL
the	NULL
identification	NULL
and	NULL
characterization	NULL
of	NULL
cell-type-specific	NULL
factors	NULL
that	NULL
regulate	NULL
expression	NULL
of	NULL
the	NULL
well-characterized	NULL
immunoglobulin	NULL
heavy	NULL
and	NULL
light	NULL
chain	NULL
genes	NULL
.	NULL

These	NULL
genes	NULL
contain	NULL
tissue-specific	NULL
promoter	NULL
and	NULL
enhancer	NULL
elements	NULL
,	NULL
and	NULL
factors	NULL
interacting	NULL
with	NULL
these	NULL
elements	NULL
have	NULL
-121	NULL
-57	NULL
==	NULL
--	NULL
-	NULL
++	NULL
-+	NULL
+	NULL
NF-KB	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

-	NULL
Transcriptional	NULL
activity	NULL
of	NULL
pure	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
vitro	NULL
.	NULL

Template	NULL
plasmids	NULL
were	NULL
digested	NULL
with	NULL
EcoRI	NULL
.	NULL

pU3R/-121	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
or	NULL
pU3R/-57	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
was	NULL
added	NULL
as	NULL
template	NULL
to	NULL
the	NULL
standard	NULL
reaction	NULL
mixtures	NULL
with	NULL
either	NULL
0.8	NULL
ul	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
or	NULL
1.6	NULL
ul	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
of	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
second-affinity-column	NULL
fraction	NULL
)	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
the	NULL
position	NULL
of	NULL
the	NULL
run-off	NULL
transcript	NULL
whose	NULL
size	NULL
(	NULL
estimated	NULL
from	NULL
markers	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
is	NULL
that	NULL
expected	NULL
for	NULL
initiation	NULL
at	NULL
the	NULL
cap	NULL
site	NULL
and	NULL
extension	NULL
to	NULL
the	NULL
EcoRI	NULL
end	NULL
at	NULL
position	NULL
+332	NULL
relative	NULL
to	NULL
the	NULL
cap	NULL
site	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
(	NULL
1988	NULL
)	NULL
4703	NULL
A	NULL
6	NULL
FCIC2C3	NULL
GFCI	NULL
C2C3	NULL
B	NULL
ICIC2F	NULL
-	NULL
I	NULL
CIC2F	NULL
wat	NULL
«	NULL
@	NULL
t	NULL
i	NULL
@	NULL
CL	NULL
i	NULL
det	NULL
F	NULL
1	NULL
as	NULL
an	NULL
*	NULL
(	NULL
«	NULL
24	NULL
a7	NULL
a~	NULL
``	NULL
N	NULL
ﬂﬁ/	NULL
Ir	NULL
wor	NULL
``	NULL
gem*	NULL
Upper	NULL
_	NULL
Lower	NULL
Upper	NULL
Lower	NULL
Strand	NULL
Strand	NULL
Strand	NULL
_	NULL
Strand	NULL
C	NULL
—11	NULL
(	NULL
|J	NULL
vv	NULL
$	NULL
1°9	NULL
-9	NULL
(	NULL
|	NULL
)	NULL
—8	NULL
(	NULL
IJ	NULL
GCTACAAGGGACTTTCCGCTGGGGACTTTCCAGGG	NULL
TGAAAGGCGACCCCTGAAAGGTCCC	NULL
CGATGTTCCC	NULL
a	NULL
an	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

DNase	NULL
I	NULL
footprinting	NULL
and	NULL
methylation-interference	NULL
analyses	NULL
of	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
an	NULL
HIV-1	NULL
promoter	NULL
fragment	NULL
probe	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Footprinting	NULL
was	NULL
performed	NULL
with	NULL
5'-labeled	NULL
(	NULL
upper	NULL
strand	NULL
)	NULL
or	NULL
3'-labeled	NULL
(	NULL
lower	NULL
strand	NULL
)	NULL
Xba	NULL
I-Pvu	NULL
II	NULL
fragment	NULL
(	NULL
from	NULL
the	NULL
Xba	NULL
I	NULL
site	NULL
in	NULL
the	NULL
vector	NULL
sequence	NULL
to	NULL
position	NULL
-19	NULL
)	NULL
of	NULL
pXRIII	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Partially	NULL
methylated	NULL
labeled	NULL
probes	NULL
described	NULL
above	NULL
were	NULL
used	NULL
for	NULL
gel	NULL
retardation	NULL
experiments	NULL
.	NULL

Procedures	NULL
were	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Positions	NULL
of	NULL
enhanced	NULL
guanines	NULL
in	NULL
the	NULL
unretarded	NULL
probe	NULL
are	NULL
marked	NULL
with	NULL
arrows	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Summary	NULL
of	NULL
the	NULL
binding	NULL
data	NULL
.	NULL

Bars	NULL
above	NULL
and	NULL
below	NULL
the	NULL
HIV-1	NULL
promoter	NULL
sequence	NULL
indicate	NULL
the	NULL
regions	NULL
protected	NULL
against	NULL
DNase	NULL
I	NULL
digestion	NULL
.	NULL

The	NULL
open	NULL
triangles	NULL
denote	NULL
guanines	NULL
whose	NULL
methylation	NULL
was	NULL
overrepresented	NULL
in	NULL
unretarded	NULL
probe	NULL
.	NULL

been	NULL
identified	NULL
by	NULL
DNA-binding	NULL
assays	NULL
(	NULL
reviewed	NULL
in	NULL
ref	NULL
.	NULL

19	NULL
)	NULL
.	NULL

We	NULL
have	NULL
purified	NULL
and	NULL
characterized	NULL
a	NULL
B-cell-specific	NULL
factor	NULL
(	NULL
octamer-binding	NULL
transcription	NULL
factor	NULL
2	NULL
)	NULL
that	NULL
interacts	NULL
with	NULL
a	NULL
sequence	NULL
(	NULL
octamer	NULL
)	NULL
present	NULL
in	NULL
heavy	NULL
and	NULL
light	NULL
chain	NULL
promoters	NULL
and	NULL
in	NULL
the	NULL
heavy	NULL
chain	NULL
enhancer	NULL
and	NULL
is	NULL
presumed	NULL
to	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
tissue-specific	NULL
function	NULL
of	NULL
these	NULL
elements	NULL
(	NULL
reviewed	NULL
in	NULL
ref	NULL
.	NULL

19	NULL
)	NULL
.	NULL

Such	NULL
a	NULL
role	NULL
was	NULL
demonstrated	NULL
for	NULL
the	NULL
k	NULL
promoter	NULL
,	NULL
which	NULL
was	NULL
activated	NULL
by	NULL
the	NULL
purified	NULL
protein	NULL
in	NULL
vitro	NULL
(	NULL
19	NULL
)	NULL
.	NULL

For	NULL
the	NULL
«	NULL
k	NULL
enhancer	NULL
,	NULL
the	NULL
main	NULL
determinant	NULL
for	NULL
tissue-specific	NULL
function	NULL
is	NULL
an	NULL
element	NULL
for	NULL
which	NULL
a	NULL
tissue-specific	NULL
binding	NULL
activity	NULL
(	NULL
designated	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
has	NULL
been	NULL
reported	NULL
(	NULL
4	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Here	NULL
we	NULL
describe	NULL
the	NULL
purification	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
affinity	NULL
chromatography	NULL
with	NULL
an	NULL
immobilized	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
k-enhancer	NULL
NF-	NULL
«	NULL
B	NULL
recognition	NULL
sequence	NULL
.	NULL

The	NULL
final	NULL
preparation	NULL
contained	NULL
a	NULL
predominant	NULL
51-kDa	NULL
polypep-tide	NULL
(	NULL
s	NULL
)	NULL
that	NULL
was	NULL
shown	NULL
by	NULL
UV	NULL
crosslinking	NULL
to	NULL
contain	NULL
the	NULL
site-specific	NULL
binding	NULL
activity	NULL
and	NULL
that	NULL
formed	NULL
two	NULL
major	NULL
complexes	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
.	NULL

These	NULL
probably	NULL
resulted	NULL
from	NULL
heterogeneity	NULL
in	NULL
the	NULL
purified	NULL
protein	NULL
,	NULL
since	NULL
a	NULL
doublet	NULL
was	NULL
observed	NULL
in	NULL
NaDodSO	NULL
,	NULL
gels	NULL
by	NULL
direct	NULL
analysis	NULL
and	NULL
after	NULL
UV	NULL
crosslinking	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
and	NULL
possible	NULL
biological	NULL
significance	NULL
of	NULL
this	NULL
heterogeneity	NULL
remains	NULL
to	NULL
be	NULL
demon-strated	NULL
,	NULL
but	NULL
similar	NULL
observations	NULL
have	NULL
been	NULL
made	NULL
for	NULL
other	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
the	NULL
CCAAT-binding	NULL
transcription	NULL
factor	NULL
(	NULL
25	NULL
)	NULL
and	NULL
the	NULL
B-cell-specific	NULL
octamer-binding	NULL
transcription	NULL
factor	NULL
2	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Purified	NULL
NF-	NULL
«	NULL
B	NULL
also	NULL
formed	NULL
two	NULL
minor	NULL
,	NULL
more	NULL
rapidly	NULL
migrating	NULL
complexes	NULL
in	NULL
the	NULL
gel	NULL
retarda-	NULL
4704	NULL
Biochemistry	NULL
:	NULL
Kawakami	NULL
et	NULL
al	NULL
.	NULL

tion	NULL
assay	NULL
,	NULL
which	NULL
may	NULL
contain	NULL
degradation	NULL
products	NULL
.	NULL

All	NULL
of	NULL
these	NULL
complexes	NULL
showed	NULL
the	NULL
same	NULL
binding	NULL
specificity	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
binding	NULL
to	NULL
the	NULL
x	NULL
enhancer	NULL
was	NULL
analyzed	NULL
in	NULL
more	NULL
detail	NULL
by	NULL
DNase-protection	NULL
and	NULL
methylation-interference	NULL
assays	NULL
,	NULL
which	NULL
revealed	NULL
binding	NULL
over	NULL
an	NULL
~=13-bp	NULL
region	NULL
containing	NULL
the	NULL
sequence	NULL
GGGACTTTCC	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Of	NULL
special	NULL
note	NULL
is	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
methylation-interference	NULL
pattern	NULL
was	NULL
identical	NULL
to	NULL
that	NULL
reported	NULL
for	NULL
the	NULL
major	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
crude	NULL
nuclear	NULL
extracts	NULL
(	NULL
or	NULL
fractions	NULL
)	NULL
(	NULL
4	NULL
)	NULL
.	NULL

This	NULL
strongly	NULL
indicates	NULL
that	NULL
the	NULL
protein	NULL
purified	NULL
was	NULL
the	NULL
B-cell-specific	NULL
factor	NULL
responsible	NULL
for	NULL
this	NULL
activity	NULL
and	NULL
not	NULL
a	NULL
ubiquitous	NULL
factor	NULL
(	NULL
H2TF1	NULL
or	NULL
KBF1	NULL
)	NULL
observed	NULL
by	NULL
others	NULL
to	NULL
interact	NULL
(	NULL
through	NULL
contacts	NULL
with	NULL
all	NULL
guanine	NULL
residues	NULL
)	NULL
with	NULL
a	NULL
related	NULL
sequence	NULL
(	NULL
GGGGATTCCCC	NULL
)	NULL
in	NULL
the	NULL
H-2K	NULL
``	NULL
enhancer	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

This	NULL
conclusion	NULL
is	NULL
supported	NULL
by	NULL
our	NULL
failure	NULL
to	NULL
detect	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
cf	NULL
.	NULL

ref	NULL
.	NULL

4	NULL
)	NULL
and	NULL
by	NULL
binding	NULL
studies	NULL
(	NULL
below	NULL
)	NULL
on	NULL
the	NULL
HIV-1	NULL
enhancer	NULL
.	NULL

The	NULL
ubiquitous	NULL
factor	NULL
recognizing	NULL
H-2K	NULL
``	NULL
promoter	NULL
elements	NULL
has	NULL
been	NULL
purified	NULL
and	NULL
identified	NULL
as	NULL
a	NULL
48-kDa	NULL
protein	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Interactions	NULL
of	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
the	NULL
HIV	NULL
promoter	NULL
were	NULL
restricted	NULL
to	NULL
one	NULL
of	NULL
the	NULL
two	NULL
potential	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

It	NULL
was	NULL
shown	NULL
(	NULL
9	NULL
)	NULL
that	NULL
one	NULL
(	NULL
or	NULL
both	NULL
)	NULL
of	NULL
these	NULL
sites	NULL
mediated	NULL
the	NULL
phorbol	NULL
ester-induced	NULL
transcription	NULL
of	NULL
the	NULL
HIV	NULL
promoter	NULL
in	NULL
a	NULL
T-cell	NULL
line	NULL
(	NULL
Jurkat	NULL
)	NULL
and	NULL
that	NULL
this	NULL
was	NULL
accompanied	NULL
by	NULL
the	NULL
induction	NULL
of	NULL
an	NULL
activity	NULL
(	NULL
presumably	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
that	NULL
bound	NULL
to	NULL
one	NULL
(	NULL
or	NULL
both	NULL
)	NULL
of	NULL
these	NULL
sites	NULL
and	NULL
to	NULL
the	NULL
x	NULL
enhancer	NULL
.	NULL

Selective	NULL
binding	NULL
of	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
the	NULL
distal	NULL
site	NULL
is	NULL
surprising	NULL
in	NULL
view	NULL
of	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
two	NULL
sites	NULL
with	NULL
each	NULL
other	NULL
and	NULL
with	NULL
the	NULL
x	NULL
enhancer	NULL
site	NULL
but	NULL
may	NULL
reflect	NULL
a	NULL
steric	NULL
problem	NULL
resulting	NULL
from	NULL
the	NULL
close	NULL
proximity	NULL
of	NULL
the	NULL
sites	NULL
.	NULL

Using	NULL
crude	NULL
extracts	NULL
from	NULL
HeLa	NULL
cells	NULL
,	NULL
others	NULL
(	NULL
29	NULL
)	NULL
have	NULL
observed	NULL
interactions	NULL
of	NULL
a	NULL
cellular	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
with	NULL
the	NULL
proximal	NULL
(	NULL
but	NULL
not	NULL
the	NULL
distal	NULL
)	NULL
element	NULL
,	NULL
whereas	NULL
extracts	NULL
from	NULL
lymphoid	NULL
or	NULL
phorbol	NULL
ester-treated	NULL
cells	NULL
showed	NULL
additional	NULL
interactions	NULL
with	NULL
the	NULL
distal	NULL
element	NULL
(	NULL
ref	NULL
.	NULL

30	NULL
,	NULL
see	NULL
also	NULL
ref	NULL
.	NULL

10	NULL
)	NULL
.	NULL

Thus	NULL
it	NULL
appears	NULL
that	NULL
the	NULL
distal	NULL
element	NULL
can	NULL
be	NULL
occupied	NULL
only	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
whereas	NULL
the	NULL
proximal	NULL
site	NULL
could	NULL
,	NULL
in	NULL
principle	NULL
,	NULL
be	NULL
occupied	NULL
either	NULL
by	NULL
a	NULL
common	NULL
cellular	NULL
factor	NULL
(	NULL
possibly	NULL
the	NULL
H2TFI	NULL
factor	NULL
discussed	NULL
above	NULL
)	NULL
or	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Although	NULL
our	NULL
observations	NULL
with	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
favor	NULL
the	NULL
hypothesis	NULL
that	NULL
the	NULL
proximal	NULL
site	NULL
can	NULL
be	NULL
occupied	NULL
only	NULL
by	NULL
a	NULL
factor	NULL
other	NULL
than	NULL
NF-kB	NULL
,	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
one	NULL
of	NULL
the	NULL
other	NULL
HIV-1	NULL
promoter	NULL
recognition	NULL
factors	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
SP1	NULL
;	NULL
ref	NULL
.	NULL

24	NULL
)	NULL
might	NULL
stabilize	NULL
interactions	NULL
of	NULL
NF-KB	NULL
at	NULL
this	NULL
site	NULL
(	NULL
cf	NULL
.	NULL

refs	NULL
.	NULL

29	NULL
and	NULL
31	NULL
)	NULL
.	NULL

Binding	NULL
and	NULL
functional	NULL
studies	NULL
(	NULL
see	NULL
below	NULL
)	NULL
with	NULL
purified	NULL
factors	NULL
,	NULL
including	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
H2TF1	NULL
,	NULL
SP1	NULL
,	NULL
and	NULL
the	NULL
TATA	NULL
factor	NULL
transcription	NULL
factor	NULL
IID	NULL
(	NULL
31	NULL
)	NULL
,	NULL
will	NULL
be	NULL
required	NULL
to	NULL
resolve	NULL
the	NULL
mechanisms	NULL
involved	NULL
in	NULL
HIV-1	NULL
promoter	NULL
activa-tion	NULL
.	NULL

The	NULL
correlations	NULL
mentioned	NULL
above	NULL
between	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
and	NULL
levels	NULL
of	NULL
«	NULL
or	NULL
HIV-1	NULL
transcription	NULL
strongly	NULL
suggest	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
serves	NULL
as	NULL
a	NULL
transcription	NULL
factor	NULL
for	NULL
these	NULL
genes	NULL
.	NULL

We	NULL
have	NULL
provided	NULL
direct	NULL
proof	NULL
for	NULL
this	NULL
supposition	NULL
by	NULL
showing	NULL
that	NULL
the	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
stimulates	NULL
transcription	NULL
from	NULL
the	NULL
HIV-1	NULL
promoter	NULL
in	NULL
HeLa	NULL
extracts	NULL
and	NULL
that	NULL
this	NULL
stimulation	NULL
is	NULL
specific	NULL
for	NULL
templates	NULL
containing	NULL
NF-	NULL
«	NULL
B-binding	NULL
sites	NULL
.	NULL

The	NULL
observed	NULL
level	NULL
of	NULL
transcriptional	NULL
stimulation	NULL
(	NULL
3-fold	NULL
)	NULL
was	NULL
not	NULL
as	NULL
great	NULL
as	NULL
that	NULL
observed	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
HIV-1	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
phorbol	NULL
ester	NULL
and	NULL
phytohemagglutinin	NULL
(	NULL
9	NULL
)	NULL
.	NULL

However	NULL
,	NULL
even	NULL
without	NULL
optimization	NULL
of	NULL
the	NULL
in	NULL
vitro	NULL
conditions	NULL
,	NULL
the	NULL
level	NULL
of	NULL
stimulation	NULL
approximated	NULL
the	NULL
level	NULL
of	NULL
induction	NULL
(	NULL
3-	NULL
to	NULL
4-fold	NULL
)	NULL
of	NULL
HIV-1	NULL
transcription	NULL
by	NULL
phorbol	NULL
ester	NULL
alone	NULL
in	NULL
intact	NULL
HeLa	NULL
cells	NULL
(	NULL
30	NULL
)	NULL
or	NULL
in	NULL
derived	NULL
extracts	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
apart	NULL
from	NULL
implicating	NULL
NF-KB	NULL
as	NULL
a	NULL
true	NULL
transcription	NULL
factor	NULL
,	NULL
the	NULL
present	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
51-kDa	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
functional	NULL
.	NULL

These	NULL
studies	NULL
represent	NULL
an	NULL
important	NULL
step	NULL
in	NULL
studying	NULL
the	NULL
structure	NULL
,	NULL
func-tion	NULL
,	NULL
and	NULL
regulation	NULL
of	NULL
a	NULL
factor	NULL
important	NULL
not	NULL
only	NULL
for	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
(	NULL
1988	NULL
)	NULL
immunoglobulin	NULL
regulation	NULL
in	NULL
B	NULL
cells	NULL
but	NULL
also	NULL
for	NULL
HIV-1	NULL
promoter	NULL
regulation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Note	NULL
Added	NULL
in	NULL
Proof	NULL
:	NULL
In	NULL
direct	NULL
footprint	NULL
analysis	NULL
,	NULL
both	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
in	NULL
HIV	NULL
promoter	NULL
were	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
treatment	NULL
by	NULL
the	NULL
purified	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

We	NULL
thank	NULL
Dr.	NULL
Masami	NULL
Horikoshi	NULL
for	NULL
valuable	NULL
discussions	NULL
throughout	NULL
this	NULL
project	NULL
;	NULL
Virginia	NULL
Kozler	NULL
and	NULL
Carmen-Gloria	NULL
Balmaceda	NULL
for	NULL
technical	NULL
assistance	NULL
;	NULL
and	NULL
Drs	NULL
.	NULL

Richard	NULL
Currie	NULL
,	NULL
Michele	NULL
Sawadogo	NULL
,	NULL
and	NULL
Craig	NULL
Rosen	NULL
for	NULL
providing	NULL
plasmid	NULL
DNAs	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grant	NULL
CA42567	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
to	NULL
R.G.R	NULL
.	NULL

and	NULL
by	NULL
general	NULL
support	NULL
from	NULL
the	NULL
Pew	NULL
Trusts	NULL
to	NULL
The	NULL
Rockefeller	NULL
University	NULL
.	NULL

C.S	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
.	NULL

Tonegawa	NULL
,	NULL
S.	NULL
(	NULL
1983	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
302	NULL
,	NULL
575-581	NULL
.	NULL

Mizushima-Sugano	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83	NULL
,	NULL
8511-8515	NULL
.	NULL

Atchison	NULL
,	NULL
M.	NULL
L.	NULL
&	NULL
Perry	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
48	NULL
,	NULL
121-128	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
705-716	NULL
.	NULL

McKnight	NULL
,	NULL
S.	NULL
L.	NULL
&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
46	NULL
,	NULL
795-805	NULL
.	NULL

Hatzopoulos	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
Schlokat	NULL
,	NULL
U	NULL
.	NULL

&	NULL
Gruss	NULL
,	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
in	NULL
Eucaryotic	NULL
RNA	NULL
Synthesis	NULL
and	NULL
Processing	NULL
,	NULL
Horizons	NULL
in	NULL
Mo	NULL
lecular	NULL
Biology	NULL
Series	NULL
,	NULL
eds	NULL
.	NULL

Hames	NULL
,	NULL
B.	NULL
D.	NULL
&	NULL
Glover	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
IRL	NULL
,	NULL
Oxford	NULL
,	NULL
Washington	NULL
,	NULL
DC	NULL
)	NULL
,	NULL
in	NULL
press	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
47	NULL
,	NULL
921-928	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
,	NULL
Pierce	NULL
,	NULL
J.	NULL
W.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
236	NULL
,	NULL
1573-1577	NULL
.	NULL

9	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
326	NULL
,	NULL
711-713	NULL
.	NULL

10	NULL
.	NULL

Dinter	NULL
,	NULL
H.	NULL
,	NULL
Chiu	NULL
,	NULL
R.	NULL
,	NULL
Imagawa	NULL
,	NULL
M.	NULL
,	NULL
Karin	NULL
,	NULL
M.	NULL
&	NULL
Jones	NULL
,	NULL
K.	NULL
A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
4067-4071	NULL
.	NULL

11	NULL
.	NULL

-	NULL
Sassone-Corsi	NULL
,	NULL
P.	NULL
,	NULL
Wildeman	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Chambon	NULL
,	NULL
P.	NULL
(	NULL
1985	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
313	NULL
,	NULL
458-463	NULL
.	NULL

12	NULL
.	NULL

-	NULL
Boshart	NULL
,	NULL
M.	NULL
,	NULL
Weber	NULL
,	NULL
F.	NULL
,	NULL
Jahn	NULL
,	NULL
G.	NULL
,	NULL
Dorsch-Hasler	NULL
,	NULL
K.	NULL
,	NULL
Fleck-enstein	NULL
,	NULL
B	NULL
.	NULL

&	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
Cell	NULL
41	NULL
,	NULL
521-530	NULL
.	NULL

13	NULL
.	NULL

Rosen	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Sodroski	NULL
,	NULL
J.	NULL
G.	NULL
&	NULL
Haseltine	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Cell	NULL
41	NULL
,	NULL
813-832	NULL
.	NULL

14	NULL
.	NULL

Kimura	NULL
,	NULL
A.	NULL
,	NULL
Israel	NULL
,	NULL
A.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
0	NULL
.	NULL

&	NULL
Kourilsky	NULL
,	NULL
P.	NULL
(	NULL
1986	NULL
)	NULL
Cell	NULL
44	NULL
,	NULL
261-272	NULL
.	NULL

15	NULL
.	NULL

Nomiyama	NULL
,	NULL
H.	NULL
,	NULL
Fromental	NULL
,	NULL
C.	NULL
,	NULL
Xiao	NULL
,	NULL
J.	NULL
H.	NULL
&	NULL
Chambon	NULL
,	NULL
P.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84	NULL
,	NULL
7881-7885	NULL
.	NULL

16	NULL
.	NULL

Max	NULL
,	NULL
E.	NULL
E.	NULL
,	NULL
Maizel	NULL
,	NULL
J.	NULL
V.	NULL
,	NULL
Jr.	NULL
,	NULL
&	NULL
Leder	NULL
,	NULL
P.	NULL
(	NULL
1981	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

256	NULL
,	NULL
5116-5120	NULL
.	NULL

17	NULL
.	NULL

Parslow	NULL
,	NULL
T.	NULL
G.	NULL
&	NULL
Granner	NULL
,	NULL
D.	NULL
K.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
4775-4792	NULL
.	NULL

18	NULL
.	NULL

Foster	NULL
,	NULL
J.	NULL
,	NULL
Stafford	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Queen	NULL
,	NULL
C.	NULL
(	NULL
1985	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
315	NULL
,	NULL
423-425	NULL
.	NULL

19	NULL
.	NULL

-	NULL
Scheidereit	NULL
,	NULL
C.	NULL
,	NULL
Heguy	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
783-793	NULL
.	NULL

20	NULL
.	NULL

Wu	NULL
,	NULL
C.	NULL
,	NULL
Wilson	NULL
,	NULL
S.	NULL
,	NULL
Walker	NULL
,	NULL
B.	NULL
,	NULL
Dawid	NULL
,	NULL
I.	NULL
,	NULL
Paisley	NULL
,	NULL
T.	NULL
,	NULL
Zimarino	NULL
,	NULL
V.	NULL
&	NULL
Ueda	NULL
,	NULL
H.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
238	NULL
,	NULL
1247-1253	NULL
.	NULL

21	NULL
.	NULL

Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
(	NULL
1970	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
227	NULL
,	NULL
680-685	NULL
.	NULL

22	NULL
.	NULL

Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83	NULL
,	NULL
5889-5893	NULL
.	NULL

23	NULL
.	NULL

Muesing	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Smith	NULL
,	NULL
D.	NULL
H.	NULL
&	NULL
Capon	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cell	NULL
48	NULL
,	NULL
691-701	NULL
.	NULL

24	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Luciw	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Science	NULL
232	NULL
,	NULL
755-759	NULL
.	NULL

25	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Rosenfeld	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Kelly	NULL
,	NULL
T.	NULL
J	NULL
.	NULL

&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
48	NULL
,	NULL
79-89	NULL
.	NULL

26	NULL
.	NULL

Israel	NULL
,	NULL
A.	NULL
,	NULL
Kimura	NULL
,	NULL
A.	NULL
,	NULL
Kieran	NULL
,	NULL
M.	NULL
,	NULL
Yano	NULL
,	NULL
O.	NULL
,	NULL
Kanellopoulos	NULL
,	NULL
J.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
0	NULL
.	NULL

&	NULL
Kourilsky	NULL
,	NULL
P.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84	NULL
,	NULL
2653-2657	NULL
.	NULL

27	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
&	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
305-313	NULL
.	NULL

28	NULL
.	NULL

Yano	NULL
,	NULL
O.	NULL
,	NULL
Kanellopoulos	NULL
,	NULL
J.	NULL
,	NULL
Kieran	NULL
,	NULL
M.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Kourilsky	NULL
,	NULL
P.	NULL
(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
3317-3324	NULL
.	NULL

29	NULL
.	NULL

Garcia	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Wu	NULL
,	NULL
F.	NULL
K.	NULL
,	NULL
Mitsuyasu	NULL
,	NULL
R.	NULL
&	NULL
Gaynor	NULL
,	NULL
R.	NULL
B	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
3761-3770	NULL
.	NULL

30	NULL
.	NULL

-	NULL
Wu	NULL
,	NULL
F.	NULL
,	NULL
Garcia	NULL
,	NULL
J.	NULL
,	NULL
Mitsuyasu	NULL
,	NULL
R.	NULL
&	NULL
Gaynor	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

62	NULL
,	NULL
218-225	NULL
.	NULL

31	NULL
.	NULL

Sawadogo	NULL
,	NULL
M.	NULL
&	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1985	NULL
)	NULL
Cell	NULL
43	NULL
,	NULL
165-175.	NULL
bP	NULL
i	NULL
a	NULL
w	NULL
pw	NULL
go	NULL
~	NULL

